Red White & Bloom Brands Inc. - RWBYF STOCK NEWS

Red White & Bloom Brands reported significant financial improvements in Q3 2024, with EBITDA increasing twenty-fold to $7.5 million YTD compared to $0.4 million in 2023. Adjusted EBITDA grew 260% to $9.6 million YTD. Revenue reached $21.7 million in Q3, up from $20.1 million in Q3 2023. The company plans to launch five new Florida medical cannabis dispensaries in Q1 2025 and has expanded its Canadian distribution to include Prince Edward Island and New Brunswick. Notable developments include 72 new product listings across provincial distributors and the launch of new cannabis products in California and Florida markets.

Red White & Bloom Brands Inc. (CSE: RWBYF) reported its Q2 2024 financial results, highlighting strategic initiatives and EBITDA growth. Key developments include:

- Advanced refinancing agreements with strategic lenders
- Progressed towards opening five new retail locations in Florida
- Established distribution partnerships in California
- Secured value-added crop commitments in Michigan
- Completed a $5.8 million non-dilutive mortgage financing for Emblem group

The company reported EBITDA of $7.1 million for H1 2024, a year-over-year improvement of over $8 million. RWB is focusing on realigning and strengthening the newly acquired Emblem Cannabis , introducing new product formats, and optimizing operations for sustainable growth.

Red White & Bloom (CSE: RWB) has released its Q1 2024 financial results. Key highlights include a revenue of $22.6 million, an increase of $2.7 million from the previous quarter but a decrease of $3.9 million compared to Q1 2023. Gross profit before fair value adjustments stood at $7.9 million. Operating expenses rose to $12.1 million due to the Aleafia acquisition. EBITDA for the quarter was $5.1 million, a significant improvement from the previous quarter's negative EBITDA. The company completed the Aleafia acquisition in January, leading to operational changes and new product introductions. RWB is focusing on restructuring financing and expanding its retail footprint in Florida while targeting profitable growth.

Red White & Bloom Brands Inc. reports fiscal 2023 annual results with an increase in adjusted EBITDA and gross profit for the second consecutive year. Annual revenue reaches $88.3 million, gross profit at $29.5 million, a 30% increase from the previous fiscal year. Adjusted EBITDA for fiscal 2023 is $5.5 million. The company focuses on higher margin revenue opportunities, restructuring financing arrangements, and expanding into new markets. RWB completes the acquisition of the Aleafia group, positioning itself for potential US federal legalization.

Red White & Bloom Brands Inc. (RWB) has successfully closed the acquisition of Aleafia Health Inc., generating C$140 million in annual revenues and C$12 million in cost synergies. The combined company will service over 2,500 retail locations in North America and international markets. The acquisition provides strategic benefits, including access to three core sales channels, virtual medical cannabis clinics, and large cultivation facilities. It is expected to be accretive on an EBITDA basis in fiscal 2024.

Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) provides an update on its ongoing transactions with Aleafia Health Inc. The Ontario Superior Court of Justice has approved the reverse vesting order, and RWB is working to implement the transactions as soon as possible. The only remaining condition is the receipt of change of control regulatory approval from Health Canada. The outside date in the Amended Stalking Horse Agreement has been extended to January 19, 2024, to accommodate the approval process.

Red White & Bloom Brands Inc. (RWB) has filed its Condensed Interim Consolidated Unaudited Financial Statements, Management Discussion and Analysis for the third quarter ended September 30, 2023. The company reported $20.1 million in revenues for Q3, with a gross profit of $7.9 million. Operating expenses saw a decrease, and adjusted EBITDA for Q3 was $1.6 million. The company is focusing on expanding its premium product line and entering new markets, with a pending acquisition that positions RWB as a leading international cannabis company in 2024.

Red White & Bloom Brands Inc. (RWB) provides an update on its collaboration with Aleafia Health Inc., including the extension of the outside date for closing the transactions contemplated under the Amended Stalking Horse Agreement to December 15, 2023.

Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) has announced its entry into the Ohio cannabis market through a strategic partnership with a vertically integrated distributor, expanding its reach to over ninety licensed retail locations. The partnership will allow RWB to introduce its Platinum Vape products to the Ohio market, capitalizing on the state's rapidly growing cannabis industry.